Effectiveness of personal protective equipment and oseltamivir prophylaxis during avian influenza a (H7N7) epidemic, the netherlands, 2003

Emerging Infectious Diseases

Volumn 16, Issue 10, 2010, Pages 1562-1568

  te Beest, Dennis E ^a,b   van Boven, Michiel ^a,b   Bos, Marian E H ^a   Stegeman, Arjan ^a   Koopmans, Marion P G ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ADULT; ARTICLE; AVIAN INFLUENZA; CONJUNCTIVITIS; EPIDEMIC; EYE PROTECTIVE DEVICE; FEMALE; HUMAN; INFECTION PREVENTION; INFECTION RISK; INFLUENZA VIRUS A H7N7; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PROTECTIVE EQUIPMENT; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; SAFETY; SEASONAL INFLUENZA;

ADOLESCENT; ADULT; ANIMAL HUSBANDRY; ANIMALS; ANTIVIRAL AGENTS; CHEMOPREVENTION; DISEASE OUTBREAKS; EYE PROTECTIVE DEVICES; FEMALE; HUMANS; INFLUENZA A VIRUS, H7N7 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NETHERLANDS; OCCUPATIONAL EXPOSURE; OSELTAMIVIR; POULTRY; POULTRY DISEASES; PROTECTIVE DEVICES; RESPIRATORY PROTECTIVE DEVICES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77958617700     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1610.091412     Document Type: Article

References (23)

1. Stegeman A, Bouma A, Elbers ARW, de Jong MCM, Nodelijk G, de Klerk F, et al. Avian influenza A virus (H7N7) epidemic in the Neth-erlands in 2003: course of the epidemic and effectiveness of control measures. J Infect Dis. 2004;190:2088-95. DOI: 10.1086/425583.
2. Koopmans M, Wilbrink B, Conyn M, Natrop G, Van der Nat H, Vennema H, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004;363:587-93. DOI: 10.1016/S0140-6736(04)15589-X
3. Fouchier RAM, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SAG, Munstert V, et al. Avian influenza A virus (H7N7) as-sociated with human conjunctivitis and a fatal case of acute respira-tory distress syndrome. Proc Natl Acad Sci U S A. 2004;101:1356-61. DOI: 10.1073/pnas.0308352100.
4. Bos MEH, te Beest DE, Van Boven M, Robert M, Meijer A, Bosman A, et al. High probability of avian influenza virus (H7N7) transmis-sion from poultry to humans active in disease control on infectedfarms. J Infect Dis. 2010;201:1390-6.
5. Bos MEH, van Boven M, Nielen M, Bouma A, Elbers ARW, Nodelijk G, et al. Estimating the day of highly pathogenic avian influenza (H7N7) virus introduction into a poultry flock based on mortality data. Vet Res. 2007;38:493-504. DOI: 10.1051/vetres:2007008.
6. Boender GJ, Hagenaars TJ, Bouma A, Nodelijk G, Elbers AR, de Jong MC, et al. Risk maps for the spread of highly pathogenic avian influenza in poultry. PLOS Comput Biol. 2007;3:e71. DOI: 10.1371/ journal.pcbi.0030071
7. Van Boven M, Koopmans M, Du Ry van Beest Holle M, Meijer A, Klinkenberg D, Donnelly CA, et al. Detecting emerging transmissibility of avian influenza virus in human households. PLOS Comput Biol. 2007;3:e145. DOI: 10.1371/journal.pcbi.0030145.
8. Du Ry Van Beest Holle M, Meijer A, Koopmans M, de Jager CM. Human-to-human transmission of avian influenza A/H7N7, the Netherlands, 2003. Eurosurveillance. 2005;10:264-8.
9. Bosman A, Mulder YM, de Leeuw JRJ, Meijer A, Du Ry Van Beest Holle M, Kamst RA, et al. Avian flu epidemic 2003: public health consequences [in Dutch]. Bilthoven, the Netherlands: National Institute for Public Health and the Environment; 2004.
10. Meijer A, Bosman A, Van de Kamp E, Wilbrink B, Holle MDR, Koopmans M. Measurement of antibodies to avian influenza virus A(H7N7) in humans by hemagglutination inhibition test. J Virol Methods. 2006;132:113-20. DOI: 10.1016/j.jviromet.2005.10.001.
11. Pawitan Y. In all likelihood: statistical modelling and inference using likelihood. 2nd ed. Oxford (UK): Clarendon Press; 2001.
12. Welliver R, Monto AS, Carewicz O, Schatteman E, Hassman M, Hedrick J, et al. Effectiveness of oseltamivir in preventing influenza in household contacts-a randomized controlled trial. JAMA. 2001;285:748-54. DOI: 10.1001/jama.285.6.748
13. Halloran ME, Hayden FG, Yang Y, Longini IM, Monto AS. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol. 2007;165:212-21. DOI: 10.1093/aje/kwj362
14. Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med. 1999;341:1336-43. DOI: 10.1056/ NEJM199910283411802.
15. Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, et al. Management of influenza in households: a prospective,randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis. 2004;189;440-9 DOI: 10.1086/381128
16. Kashiwagi S, Kudoh S, Watanabe A, Yoshimura I. Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza-placebo-controlled double-blind multicenter phase III trial. Kansenshogaku Zasshi. 2000;74:1062-76.
17. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet. 2006;367:303-13. DOI: 10.1016/S0140-6736(06)67970-1.
18. Skowronski DM, Li Y, Tweed SA, Tam TWS, Petric M, David ST, et al. Protective measures and human antibody response during an avi- an influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ. 2007;176:47-53. DOI: 10.1503/cmaj.060204
19. Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis. 2004;10:2196-9.
20. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA. 2009;301:103441. DOI: 10.1001/jama.2009.294.
21. Van der Sande M, Teunis P, Sabel R. Professional and home-made face masks reduce exposure to respiratory infections among the general population. PLoS One. 2008;3:e2618. DOI: 10.1371/journal. pone.0002618.
22. Balazy A, Toivola M, Adhikari A, Sivasubramani SK, Reponen T, Grinshpun SA. Do N95 respirators provide 95% protection level against airborne viruses, and how adequate are surgical masks? Am J Infect Control. 2006;34:51-7. DOI: 10.1016/j.ajic.2005.08.018.
23. Morgan O, Kuhne M, Nair P, Verlander NQ, Preece R, McDougal M, et al. Personal protective equipment and risk for avian influenza (H7N3). Emerg Infect Dis. 2009;15:59-62. DOI: 10.3201/eid1501.070660.